Active	Status	Sponsor type	Region	Phase	Filter
1 Active 5 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gisondi, Paolo
NCT04469829: Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome	Not yet recruiting	4	70	Europe	Secukinumab, Methotrexate	Universita di Verona	Psoriasis, Metabolic Syndrome	12/21	12/22